⌘K

Login Start Free

Home/Filings/4/0001144204-16-110083

4//SEC Filing

CASI Pharmaceuticals, Inc. 4

Accession 0001144204-16-110083

CIK 0000895051operating

View on SEC.gov Company Profile

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 6:59 PM ET

Size

5.3 KB

Accession

0001144204-16-110083

Insider Transaction Report

Form 4

Period: 2016-06-24

CASI Pharmaceuticals, Inc.CASI

COO & General Counsel

Transactions

Award
Stock Options (Right to Buy)
2016-06-24+27,027→ 27,027 total
Exercise: $1.15From: 2016-06-24Exp: 2026-06-24→ Common Stock (27,027 underlying)

Documents

1 file

4
v443081_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000895051

Filing Metadata

Form type: 4
Filed: Jun 26, 8:00 PM ET
Accepted: Jun 27, 6:59 PM ET
Size: 5.3 KB

View on SEC.gov